{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:55:49Z","timestamp":1785293749057,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":552,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2012\u201338957"],"award-info":[{"award-number":["SAF2012\u201338957"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2015\u201367485-R"],"award-info":[{"award-number":["SAF2015\u201367485-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1074\/jbc.ra118.005828","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T22:45:10Z","timestamp":1549406710000},"page":"5214-5227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Insights into ligand binding by a viral tumor necrosis factor (TNF) decoy receptor yield a selective soluble human type 2 TNF receptor"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-9831","authenticated-orcid":false,"given":"Sergio M.","family":"Pontejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Ruiz-Arg\u00fcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3333-6016","authenticated-orcid":false,"given":"Antonio","family":"Alcami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.005828_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/jbc.RA118.005828_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol"},{"key":"10.1074\/jbc.RA118.005828_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.trsl.2014.09.006","article-title":"Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases","volume":"165","author":"Willrich","year":"2015","journal-title":"Transl. Res"},{"key":"10.1074\/jbc.RA118.005828_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1177\/106002809703101111","article-title":"Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis","volume":"31","author":"Murray","year":"1997","journal-title":"Ann. Pharmacother"},{"key":"10.1074\/jbc.RA118.005828_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000354703","article-title":"Adverse events of tumor necrosis factor inhibitors","volume":"31","author":"Fellermann","year":"2013","journal-title":"Dig. Dis"},{"key":"10.1074\/jbc.RA118.005828_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cyto.2016.08.014","article-title":"Molecular mechanisms of action of anti-TNF-\u03b1 agents\u2014comparison among therapeutic TNF-\u03b1 antagonists","volume":"101","author":"Mitoma","year":"2018","journal-title":"Cytokine"},{"key":"10.1074\/jbc.RA118.005828_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4419-6612-4_21","article-title":"Poxviral TNFRs: properties and role in viral pathogenesis","volume":"691","author":"Alejo","year":"2011","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1074\/jbc.RA118.005828_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/viro.1994.1539","article-title":"Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor","volume":"204","author":"Hu","year":"1994","journal-title":"Virology"},{"key":"10.1074\/jbc.RA118.005828_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1996.0462","article-title":"Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT\u03b1","volume":"223","author":"Smith","year":"1996","journal-title":"Virology"},{"key":"10.1074\/jbc.RA118.005828_bib10","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1073\/pnas.95.7.3786","article-title":"A third distinct tumor necrosis factor receptor of orthopoxviruses","volume":"95","author":"Loparev","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.005828_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/JVI.75.1.226-233.2001","article-title":"CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses","volume":"75","author":"Saraiva","year":"2001","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.005828_bib12","doi-asserted-by":"crossref","first-page":"15973","DOI":"10.1074\/jbc.M115.650119","article-title":"Comparative biochemical and functional analysis of viral and human secreted tumor necrosis factor (TNF) decoy receptors","volume":"290","author":"Pontejo","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005828_bib13","doi-asserted-by":"crossref","first-page":"13964","DOI":"10.1074\/jbc.M601553200","article-title":"Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human","volume":"281","author":"Bossen","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005828_bib14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jmb.2007.06.082","article-title":"Structure of CrmE, a virus-encoded tumour necrosis factor receptor","volume":"372","author":"Graham","year":"2007","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.RA118.005828_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0968-0004(97)01164-X","article-title":"Modularity in the TNF-receptor family","volume":"23","author":"Naismith","year":"1998","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/jbc.RA118.005828_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0968-0004(01)01995-8","article-title":"The molecular architecture of the TNF superfamily","volume":"27","author":"Bodmer","year":"2002","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/jbc.RA118.005828_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.sbi.2004.03.003","article-title":"Tumor necrosis factor family ligand-receptor binding","volume":"14","author":"Zhang","year":"2004","journal-title":"Curr. Opin. Struct. Biol"},{"key":"10.1074\/jbc.RA118.005828_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1097-2765(00)80207-5","article-title":"Triggering cell death: the crystal structure of Apo2L\/TRAIL in a complex with death receptor 5","volume":"4","author":"Hymowitz","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA118.005828_bib19","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.0904033","article-title":"Structural and functional insights of RANKL-RANK interaction and signaling","volume":"184","author":"Liu","year":"2010","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.005828_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.str.2010.12.004","article-title":"Decoy strategies: the structure of TL1A:DcR3 complex","volume":"19","author":"Zhan","year":"2011","journal-title":"Structure"},{"key":"10.1074\/jbc.RA118.005828_bib21","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1126\/science.288.5475.2351","article-title":"A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling","volume":"288","author":"Chan","year":"2000","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.005828_bib22","doi-asserted-by":"crossref","first-page":"ra83","DOI":"10.1126\/scisignal.2000954","article-title":"Solution of the structure of the TNF-TNFR2 complex","volume":"3","author":"Mukai","year":"2010","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.RA118.005828_bib23","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.288.5475.2354","article-title":"Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations","volume":"288","author":"Siegel","year":"2000","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.005828_bib24","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/jvi.71.3.2171-2181.1997","article-title":"Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition","volume":"71","author":"Schreiber","year":"1997","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.005828_bib25","doi-asserted-by":"crossref","first-page":"9300","DOI":"10.1128\/JVI.02449-05","article-title":"Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death","volume":"80","author":"Sedger","year":"2006","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.005828_bib26","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.0510462103","article-title":"A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus","volume":"103","author":"Alejo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.005828_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04098-8","article-title":"Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation","volume":"9","author":"Alejo","year":"2018","journal-title":"Nat. Commun"},{"issue":"Suppl. 1","key":"10.1074\/jbc.RA118.005828_bib28","doi-asserted-by":"crossref","first-page":"i50","DOI":"10.1136\/ard.59.suppl_1.i50","article-title":"The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function","volume":"59","author":"Chan","year":"2000","journal-title":"Ann. Rheum. Dis"},{"key":"10.1074\/jbc.RA118.005828_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-A","article-title":"Crystal structure of the soluble human 55 kd TNF receptor-human TNF\u03b2 complex: implications for TNF receptor activation","volume":"73","author":"Banner","year":"1993","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.005828_bib30","doi-asserted-by":"crossref","first-page":"31171","DOI":"10.1074\/jbc.M004414200","article-title":"Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity","volume":"275","author":"Cha","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005828_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tibs.2012.06.002","article-title":"An improved understanding of TNFL\/TNFR interactions using structure-based classifications","volume":"37","author":"Magis","year":"2012","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/jbc.RA118.005828_bib32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.str.2006.06.015","article-title":"The crystal structure of the costimulatory OX40-OX40L complex","volume":"14","author":"Compaan","year":"2006","journal-title":"Structure"},{"key":"10.1074\/jbc.RA118.005828_bib33","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.str.2012.08.030","article-title":"RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor","volume":"20","author":"Nelson","year":"2012","journal-title":"Structure"},{"key":"10.1074\/jbc.RA118.005828_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.1103387","article-title":"Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin","volume":"189","author":"Luan","year":"2012","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.005828_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/viro.2001.1236","article-title":"Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence","volume":"292","author":"Reading","year":"2002","journal-title":"Virology"},{"key":"10.1074\/jbc.RA118.005828_bib36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/mgme.1999.2878","article-title":"Tumor necrosis factor receptors encoded by poxviruses","volume":"67","author":"Cunnion","year":"1999","journal-title":"Mol. Genet. Metab"},{"key":"10.1074\/jbc.RA118.005828_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002162","article-title":"Structural basis of chemokine sequestration by CrmD, a poxvirus-encoded tumor necrosis factor receptor","volume":"7","author":"Xue","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.RA118.005828_bib38","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.4049\/jimmunol.157.10.4486","article-title":"Mutational analysis of the ligand-binding domain of M-T2 protein, the tumor necrosis factor receptor homologue of myxoma virus","volume":"157","author":"Schreiber","year":"1996","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.005828_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2007.03.005","article-title":"Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling","volume":"37","author":"Chan","year":"2007","journal-title":"Cytokine"},{"key":"10.1074\/jbc.RA118.005828_bib40","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1074\/jbc.M112.427583","article-title":"Cysteine-rich domain 1 of CD40 mediates receptor self-assembly","volume":"288","author":"Smulski","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005828_bib41","doi-asserted-by":"crossref","first-page":"18099","DOI":"10.1073\/pnas.0507329102","article-title":"Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis","volume":"102","author":"Clancy","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.005828_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cellsig.2009.10.011","article-title":"Dual function of cysteine rich domain (CRD) 1 of TNF receptor type 1: conformational stabilization of CRD2 and control of receptor responsiveness","volume":"22","author":"Bransch\u00e4del","year":"2010","journal-title":"Cell. Signal"},{"key":"10.1074\/jbc.RA118.005828_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/protein\/3.8.713","article-title":"Mutational analysis of structure\u2013activity relationships in human tumor necrosis factor-\u03b1","volume":"3","author":"Yamagishi","year":"1990","journal-title":"Protein Eng"},{"key":"10.1074\/jbc.RA118.005828_bib44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/protein\/4.7.785","article-title":"Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor \u03b2 (lymphotoxin)","volume":"4","author":"Goh","year":"1991","journal-title":"Protein Eng"},{"key":"10.1074\/jbc.RA118.005828_bib45","doi-asserted-by":"crossref","first-page":"18827","DOI":"10.1074\/jbc.272.30.18827","article-title":"Characterization of Fas (Apo-1, CD95)-Fas ligand interaction","volume":"272","author":"Schneider","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005828_bib46","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/bi992242l","article-title":"A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L\/TRAIL","volume":"39","author":"Hymowitz","year":"2000","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA118.005828_bib47","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1021\/bi900031w","article-title":"Biochemical and structural characterization of the human TL1A ectodomain","volume":"48","author":"Zhan","year":"2009","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA118.005828_bib48","doi-asserted-by":"crossref","first-page":"14307","DOI":"10.1074\/jbc.275.19.14307","article-title":"The lymphotoxin-\u03b2 receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells","volume":"275","author":"Rooney","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005828_bib49","doi-asserted-by":"crossref","first-page":"28889","DOI":"10.1074\/jbc.272.46.28889","article-title":"Requirement of cysteine-rich repeats of the Fas receptor for binding by the Fas ligand","volume":"272","author":"Orlinick","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005828_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009742.2013.834964","article-title":"Etanercept decreases synovial expression of tumour necrosis factor-\u03b1 and lymphotoxin-\u03b1 in rheumatoid arthritis","volume":"43","author":"Nereg\u00e5rd","year":"2014","journal-title":"Scand. J. Rheumatol"},{"key":"10.1074\/jbc.RA118.005828_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s13075-014-0467-3","article-title":"Efficacy and safety of pateclizumab (anti-lymphotoxin-\u03b1) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)","volume":"16","author":"Kennedy","year":"2014","journal-title":"Arthritis Res. Ther"},{"key":"10.1074\/jbc.RA118.005828_bib52","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.4049\/jimmunol.168.7.3394","article-title":"Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Gu\u00e9rin infection in the absence of secreted TNF and lymphotoxin-alpha","volume":"168","author":"Olleros","year":"2002","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.005828_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1084\/jem.193.2.239","article-title":"Secreted lymphotoxin-\u03b1 is essential for the control of an intracellular bacterial infection","volume":"193","author":"Roach","year":"2001","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA118.005828_bib54","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.4049\/jimmunol.170.10.5210","article-title":"The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes","volume":"170","author":"Ehlers","year":"2003","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.005828_bib55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect. Dis"},{"key":"10.1074\/jbc.RA118.005828_bib56","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/1521-4141(200106)31:6<1935::AID-IMMU1935>3.0.CO;2-N","article-title":"Differential effects of TNF and LT\u03b1 in the host defense against M. bovis BCG","volume":"31","author":"Bopst","year":"2001","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/jbc.RA118.005828_bib57","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/clim.2000.4835","article-title":"Fatal Mycobacterium bovis BCG infection in TNF-LT-\u03b1-deficient mice","volume":"94","author":"Jacobs","year":"2000","journal-title":"Clin. Immunol"},{"key":"10.1074\/jbc.RA118.005828_bib58","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin. Infect. Dis"},{"key":"10.1074\/jbc.RA118.005828_bib59","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.23447","article-title":"Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor \u03b1-expressing cells: comparison among infliximab, etanercept, and adalimumab","volume":"58","author":"Mitoma","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1074\/jbc.RA118.005828_bib60","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1136\/annrheumdis-2012-202220","article-title":"The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis","volume":"72","author":"Garc\u00eas","year":"2013","journal-title":"Ann. Rheum. Dis"},{"key":"10.1074\/jbc.RA118.005828_bib61","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1096\/fj.10-177188","article-title":"Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses","volume":"25","author":"Montanuy","year":"2011","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA118.005828_bib62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER Suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820355733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820355733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.005828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T12:02:43Z","timestamp":1694606563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820355733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":62,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0021925820355733"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.005828","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into ligand binding by a viral tumor necrosis factor (TNF) decoy receptor yield a selective soluble human type 2 TNF receptor","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.005828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Pontejo et al.","name":"copyright","label":"Copyright"}]}}